{"timestamp": 1771594778.344438, "value": {"ticker": "LEXX", "company_name": "Lexaria Bioscience Corp.", "short_name": "Lexaria Bioscience Corp.", "sector": "Healthcare", "industry": "Biotechnology", "country": "Canada", "market_cap": 16420737, "float_shares": 23538795, "shares_outstanding": 24887446, "short_ratio": 2.4, "short_percent_of_float": 0.026300002, "shares_short": 631202, "shares_short_prior": 1596738, "insider_percent_held": 0.0612, "institution_percent_held": 0.06954, "total_cash": 4424500, "total_debt": 101920, "total_revenue": 522000, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 1.0, "operating_margins": -20.14616, "debt_to_equity": 2.253, "current_ratio": 3.682, "book_value": 0.221, "price_to_book": 2.9855204, "operating_cashflow": -8708440, "free_cashflow": -4779293, "price": 0.6598, "52w_high": 1.896, "52w_low": 0.46, "avg_volume": 631273, "avg_volume_10d": 208680, "full_time_employees": 7, "audit_risk": 0, "overall_risk": 0}}